³ÉÈË¿ìÊÖ

We have made absolutely clear the commitment of this government to promoting and supporting children’s mental health and wellbeing, through wide ranging commitments in our Programme for Government.

Those commitments build on the responsibilities of education authorities to identify, provide for, and to review the additional support needs of their pupils, under the Additional Support for Learning Act. The Act enables education authorities to seek help from other agencies in delivering these duties. This includes support for improving the mental health of pupils provided by occupational therapy services.

The Plan articulates a move to a preventive care system where patients would be seen according to their oral health need. This means that patients may be seen more frequently than currently if they have poor oral health and some less frequently if their level of oral health and general health justifies it. This model is supported by National Institute and Clinical Excellence (NICE) Guidelines on the frequency of dental check-ups.

The model of care we propose also includes an Oral Health Risk Assessment and personalised care plan for adult patients in relation to oral cancer, gum disease and decay according to their degree of risk. This is a considerable enhancement on the current check-up regime.

Patients who need a scale and polish will continue to receive this treatment. Recent evidence from the iQUAD study led by the University of Dundee and the Health Services Research Unit in the University of Aberdeen has informed the policy. In the future the emphasis will be on treating periodontal disease. For patients with periodontal disease or a high risk of developing it, the intention is to ensure these patients receive a clinically proven programme of periodontal care.

Yes. The Scottish Medicines Consortium (SMC) has determined, further to a request from the Chief Pharmaceutical Officer, that Orkambi ® is not suitable for assessment under the new ultra-orphan pathway. The SMC has come to this view having regard to the approximately 900 people in Scotland who suffer from cystic fibrosis. The ultra-orphan pathway is intended for conditions with a prevalence of 1 in 50,000 or less, equivalent to around 100 people in Scotland. The SMC takes decisions independently of Ministers.

The Scottish Government continues to call upon the manufacturer of Orkambi ® , Vertex Pharmaceuticals, to make a new submission to the SMC, at a fair price that allows general access on the NHS. Clinicians may also apply for individual patients to have access to the medicine, through the Peer Approved Clinical System (PACS) Tier Two, which has been in place since June 2018. The Scottish Government is collecting information from Health Boards about the use of PACS Tier Two and plans to publish statistics as part of the previously announced reviews of the new process six and twelve months after its commencement.

On 20 March 2018 the then Cabinet Secretary, Shona Robison MSP, announced to Parliament that she had asked Health Protection Scotland (HPS) to undertake a thorough investigation of this incident. This investigation is on-going and once it has concluded a report will be provided. This report will address the incident in full and the outcomes will be used to inform learning for NHSScotland.

Regarding the incident in 2015, NHS Greater Glasgow and Clyde has confirmed that HPS conducted a thorough investigation of the incident and concluded that it was not related to bacteria in the water.

The Oral Health Improvement Plan sets out a programme of phased introduction of Oral Health Risk Assessments (OHRA) for adult patients. The purpose of these assessments is to ensure that patients receive personalised care plans in relation to oral cancer, gum disease and decay according to their degree of risk.

The intention would be to link any future payments to actual care and treatment provided by GDPs, in this case the assessment, and any related treatment. In developing the OHRA cognisance will be taken of the need to the train dentists in effective communication skills.

The new domiciliary care arrangements will include a comprehensive training programme developed in conjunction with NHS Education for Scotland. GDPs with enhanced skills in domiciliary care will be required to successfully complete the training programme that will take cognisance of the relevant standards for the provision of dental care and treatment.

Total expenditure on NHS Dental Services for the last five years is set out in the following table, gross and net of patient charges revenue. Expenditure includes General Dental Services, Public Dental Services and the following hospital specialties: Dental, Oral Surgery and Medicine, Maxillofacial Surgery and AHP Outpatient service provided by Dental Ancillary staff. This information is based on Scottish Health Service Costs, an annual publication from ISD Scotland. Over the five year period, gross expenditure per head of population has risen by 3.1% and net expenditure per head by 3.6%.

The Scottish Government takes advice from the UK National Screening Committee (UK NSC), an independent expert advisory group which advises Ministers and the NHS in the four UK countries about all aspects of screening policy.

The UK NSC are currently reviewing the evidence for HPV self-sampling as an additional test to address non-attendance within the NHS Cervical Screening Programme. We await advice from the UK NSC and will carefully consider any recommendations provided.

The information requested is not available in entirety.

The Higher Education Statistics Agency (HESA) collects, processes and publishes data about Higher Education delivered at Higher Education Institutions (HEIs) in the UK, including at both undergraduate and postgraduate level.

HESA introduced a question in 2016-17 in the Destination of Leavers from Higher Education (DLHE) survey that records whether a recent leaver from University is working for the NHS. This information, combined with location of work, can provide an estimate of the proportion of leavers working for NHS Scotland. As the DLHE is an optional survey of leavers, numbers reflect only those students who have responded to the survey –typically around 80% for leavers from medicine courses.

The following table has been split into ‘first degree clinical medicine’ leavers (typical medical graduates) and ‘All’ leavers which will include other undergraduate and postgraduate study.

Destinations of known Scottish domiciled first degree leavers in a medicine subject,

6 months after leaving in 2016-17

Source: HESA Destination of Leavers from Higher Education (DLHE)

Notes:

• Data based on DLHE sample survey, 6 months after leaving, and represents around 80% of leavers from medicine courses.
• Scottish domiciled students at Scottish HEIs
• Numbers rounded to nearest 5, percentages based on unrounded numbers, but supressed if relating to less than 22.5 leavers.
• Results based on HESA variable NHSORG
• Those working and involved in further study have been counted as working.
• Other Destination includes ‘Further Study’, 'Unemployed', 'Other Destinations’ and ‘Unknown’'.

‘All Medical Subject Leavers’ includes all pre-clinical and clinical undergraduate and postgraduate leavers. Pre-clinical undergraduate leavers will typically be from St Andrews University who will undertake clinical medicine at a separate university. At postgraduate level this covers a range of study at Masters and PhD level, over a wide range of courses at clinical medicine (including Child Health, Surgical Sciences and Cardiovascular Sciences to name a few), and pre-clinical medicine (including Physician Associate Studies).